All research is designed by licensed M.D.'s. To request a copy of our clinical research as it is made publically available
As with any medication, whether obtained over-the-counter or by prescription, keep in mind Corprofen™ is a drug. Prior to use, the patient should discuss product use with their treating physician, physical therapist, chiropractor, or healthcare professional (hereinafter referred to as "healthcare professional").
Dosage Application
Corprofen™ is for external use on the skin (clean skin).
Gently massage a thin film of Corprofen™ to your fibromyagia pain sites 1 or 2 times per day or as directed by a healthcare professional. Discontinue use of Corprofen™ when pain control is achieved. If your fibromyalgia pain does not improve within one week, contact your healthcare professional.
Patient Information
Corprofen™ is not intended to diagnose, treat, cure, or prevent any disease.
Corprofen™ is to be used only as directed by a healthcare professional. Do not use for any condition other than that for which it is recommended.
Do not use Corprofen™ longer than recommended. Corprofen™ is for external use only. Avoid mucus membranes (eyes, mouth, anus, and vagina). Unless directed by a healthcare professional, avoid use on the face, underarms, or groin.
Do not apply Corprofen™ on skin infection, skin rash, open skin, or wounds.
Discontinue use of Corprofen™ if any signs of adverse reaction develop (e.g. rash, itching). Report any adverse reactions to the recommending healthcare professional.
Do not cover skin treated with Corprofen™ with an airtight dressing (e.g. adhesive bandage, plastic wrap).
Precautions
As with any medication, whether obtained over-the-counter or by prescription, keep in mind Corprofen™ is a drug. Prior to use, the patient should discuss product use with a healthcare professional.
Do not use Corprofen™ if sensitive to hydrocortisone or any other steroid medication, aspirin, ibuprofen, or lidocaine. In patients with diabetes mellitus (sugar diabetes), overuse of corticosteroids may interfere with the patient's ability to control diabetes by increasing blood and urine glucose (sugar). However, this is not likely to occur when Corprofen™ is used for a short period of time.
Prolonged use of hydrocortisone can depress the ability of the body's adrenal glands to produce corticosteroids and may cause corticosteroid insufficiency. Nausea, vomiting, and even shock may accompany corticosteroid insufficiency. Therefore, patients who have used hydrocortisone for a prolonged period of time should not abruptly stop its use. Withdrawal from use of hydrocortisone should be done gradually under a healthcare professional's direction. Gradually tapering from hydrocortisone use may minimize the risk of abrupt flare of the disease under treatment.
In patients with tuberculosis, corticosteroids may make existing infection worse or may cause new infections.
In patients with thinning skin with easy bruising, corticosteroids may make the condition worse.
Products containing lidocaine may not be recommended for use by patients with liver problems or other serious medical conditions.
Pregnant/Breastfeeding: Pregnant/Breastfeeding women should avoid use of Corprofen™.
Children: Use of Corprofen™ is not recommended for children under 18 years of age, unless directed by a healthcare professional.
Corprofen™ is manufactured in an FDA inspected OTC-licensed facility. Corprofen™ is exclusively distributed by Corprofen, Inc.